Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

Clinical trial NCT01342289 · COMPLETED

Trial details

NCT number: NCT01342289
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hodgkin's Lymphoma Leukemia Myelodysplastic Syndrome(MDS)Multiple Myeloma Non Hodgkin's Lymphoma

Start date: 2011-08-01
Primary completion: 2018-03-01
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.